A novel high-throughput microwell outgrowth assay for HIV-infected cells.
J Virol.
2024 Mar 19;98(3):e0179823. doi: 10.1128/jvi.01798-23. Epub 2024 Feb 20. PubMed PMID:
38376258; PubMed Central PMCID:
PMC10949454.
Stoichiometry for entry and binding properties of the Env protein of R5 T cell-tropic HIV-1 and its evolutionary variant of macrophage-tropic HIV-1.
mBio.
2024 Mar 1;:e0032124. doi: 10.1128/mbio.00321-24. [Epub ahead of print] PubMed PMID:
38426750.
The timing of HIV-1 infection of cells that persist on therapy is not strongly influenced by replication competency or cellular tropism of the provirus.
PLoS Pathog.
2024 Feb;20(2):e1011974. doi: 10.1371/journal.ppat.1011974. eCollection 2024 Feb. PubMed PMID:
38422171; PubMed Central PMCID:
PMC10931466.
Brain microglia serve as a persistent HIV reservoir despite durable antiretroviral therapy.
J Clin Invest.
2023 Jun 15;133(12). doi: 10.1172/JCI167417. PubMed PMID:
37317962; PubMed Central PMCID:
PMC10266791.
Biotypes of Central Nervous System Complications in People With Human Immunodeficiency Virus: Virology, Immunology, and Neuropathology.
J Infect Dis.
2023 Mar 17;227(Suppl 1):S3-S15. doi: 10.1093/infdis/jiac370. PubMed PMID:
36930640; PubMed Central PMCID:
PMC10022721.
Rebound HIV-1 in cerebrospinal fluid after antiviral therapy interruption is mainly clonally amplified R5 T cell-tropic virus.
Nat Microbiol.
2023 Feb;8(2):260-271. doi: 10.1038/s41564-022-01306-6. Epub 2023 Jan 30. PubMed PMID:
36717718; PubMed Central PMCID:
PMC10201410.
Cardiovascular Disease and Thrombosis in HIV Infection.
Arterioscler Thromb Vasc Biol.
2023 Feb;43(2):175-191. doi: 10.1161/ATVBAHA.122.318232. Epub 2022 Dec 1. Review. PubMed PMID:
36453273; PubMed Central PMCID:
PMC10165851.
HIV-1 is Transported into the Central Nervous System by Trafficking Infected Cells.
Pathog Immun.
2022;7(2):131-142. doi: 10.20411/pai.v7i2.524. eCollection 2022. PubMed PMID:
36865569; PubMed Central PMCID:
PMC9973728.
Characterization of Macrophage-Tropic HIV-1 Infection of Central Nervous System Cells and the Influence of Inflammation.
J Virol.
2022 Sep 14;96(17):e0095722. doi: 10.1128/jvi.00957-22. Epub 2022 Aug 17. PubMed PMID:
35975998; PubMed Central PMCID:
PMC9472603.
Stable Latent HIV Infection and Low-level Viremia Despite Treatment With the Broadly Neutralizing Antibody VRC07-523LS and the Latency Reversal Agent Vorinostat.
J Infect Dis.
2022 Mar 2;225(5):856-861. doi: 10.1093/infdis/jiab487. PubMed PMID:
34562096; PubMed Central PMCID:
PMC8889279.
Immunological Correlates of the HIV-1 Replication-Competent Reservoir Size.
Clin Infect Dis.
2021 Oct 20;73(8):1528-1531. doi: 10.1093/cid/ciab587. PubMed PMID:
34181706; PubMed Central PMCID:
PMC8528395.
The HIV-1 latent reservoir is largely sensitive to circulating T cells.
Elife.
2020 Oct 6;9. doi: 10.7554/eLife.57246. PubMed PMID:
33021198; PubMed Central PMCID:
PMC7593086.
Improved killing of HIV-infected cells using three neutralizing and non-neutralizing antibodies.
J Clin Invest.
2020 Oct 1;130(10):5157-5170. doi: 10.1172/JCI135557. PubMed PMID:
32584790; PubMed Central PMCID:
PMC7524508.
Macrophage Tropism in Pathogenic HIV-1 and SIV Infections.
Viruses.
2020 Sep 25;12(10). doi: 10.3390/v12101077. Review. PubMed PMID:
32992787; PubMed Central PMCID:
PMC7601331.
Curing HIV: Seeking to Target and Clear Persistent Infection.
Cell.
2020 Apr 2;181(1):189-206. doi: 10.1016/j.cell.2020.03.005. Epub 2020 Mar 26. Review. PubMed PMID:
32220311; PubMed Central PMCID:
PMC7896558.
Measuring the contribution of γδ T cells to the persistent HIV reservoir.
AIDS.
2020 Mar 1;34(3):363-371. doi: 10.1097/QAD.0000000000002434. PubMed PMID:
31764074; PubMed Central PMCID:
PMC6994336.
What can characterization of cerebrospinal fluid escape populations teach us about viral reservoirs in the central nervous system?.
AIDS.
2019 Dec 1;33 Suppl 2:S171-S179. doi: 10.1097/QAD.0000000000002253. Review. PubMed PMID:
31790378.
The replication-competent HIV-1 latent reservoir is primarily established near the time of therapy initiation.
Sci Transl Med.
2019 Oct 9;11(513). doi: 10.1126/scitranslmed.aaw5589. PubMed PMID:
31597754; PubMed Central PMCID:
PMC7233356.
Blocking Formation of the Stable HIV Reservoir: A New Perspective for HIV-1 Cure.
Front Immunol.
2019;10:1966. doi: 10.3389/fimmu.2019.01966. eCollection 2019. Review. PubMed PMID:
31507594; PubMed Central PMCID:
PMC6714000.
Predicting Efavirenz Concentrations in the Brain Tissue of HIV-Infected Individuals and Exploring their Relationship to Neurocognitive Impairment.
Clin Transl Sci.
2019 May;12(3):302-311. doi: 10.1111/cts.12620. Epub 2019 Feb 27. PubMed PMID:
30675981; PubMed Central PMCID:
PMC6510381.
HIV-1 detection in the olfactory mucosa of HIV-1-infected participants.
AIDS.
2019 Mar 15;33(4):665-674. doi: 10.1097/QAD.0000000000002102. PubMed PMID:
30608272.
Longitudinal HIV sequencing reveals reservoir expression leading to decay which is obscured by clonal expansion.
Nat Commun.
2019 Feb 13;10(1):728. doi: 10.1038/s41467-019-08431-7. PubMed PMID:
30760706; PubMed Central PMCID:
PMC6374386.
The evolution of HIV-1 entry phenotypes as a guide to changing target cells.
J Leukoc Biol.
2018 Mar;103(3):421-431. doi: 10.1002/JLB.2RI0517-200R. Epub 2018 Feb 1. Review. PubMed PMID:
29389021.
Symptomatic cerebrospinal fluid HIV-1 escape with no resistance-associated mutations following low-level plasma viremia.
J Neurovirol.
2018 Feb;24(1):132-136. doi: 10.1007/s13365-017-0605-1. Epub 2017 Dec 14. PubMed PMID:
29243133.
Evolution of Host Target Cell Specificity During HIV-1 Infection.
Curr HIV Res.
2018;16(1):13-20. doi: 10.2174/1570162X16666171222105721. Review. PubMed PMID:
29268687.
Highlights of the Global HIV-1 CSF Escape Consortium Meeting, 9 June 2016, Bethesda, MD, USA.
J Virus Erad.
2016 Oct 5;2(4):243-250. PubMed PMID:
27781109; PubMed Central PMCID:
PMC5075354.
Phenotypic Correlates of HIV-1 Macrophage Tropism.
J Virol.
2015 Nov;89(22):11294-311. doi: 10.1128/JVI.00946-15. Epub 2015 Sep 2. PubMed PMID:
26339058; PubMed Central PMCID:
PMC4645658.
Bottlenecks in HIV-1 transmission: insights from the study of founder viruses.
Nat Rev Microbiol.
2015 Jul;13(7):414-25. doi: 10.1038/nrmicro3471. Epub 2015 Jun 8. Review. PubMed PMID:
26052661; PubMed Central PMCID:
PMC4793885.
HIV-1 target cells in the CNS.
J Neurovirol.
2015 Jun;21(3):276-89. doi: 10.1007/s13365-014-0287-x. Epub 2014 Sep 19. Review. PubMed PMID:
25236812; PubMed Central PMCID:
PMC4366351.
Compartmentalized replication of R5 T cell-tropic HIV-1 in the central nervous system early in the course of infection.
PLoS Pathog.
2015 Mar;11(3):e1004720. doi: 10.1371/journal.ppat.1004720. eCollection 2015 Mar. PubMed PMID:
25811757; PubMed Central PMCID:
PMC4374811.
HIV/AIDS. A fitness bottleneck in HIV-1 transmission.
Science.
2014 Jul 11;345(6193):136-7. doi: 10.1126/science.1257425. PubMed PMID:
25013044.
Dominance effects of deleterious and beneficial mutations in a single gene of the RNA virus ϕ6.
PLoS One.
2014;9(6):e97717. doi: 10.1371/journal.pone.0097717. eCollection 2014. PubMed PMID:
24945910; PubMed Central PMCID:
PMC4063744.
Evolving character of chronic central nervous system HIV infection.
Semin Neurol.
2014 Feb;34(1):7-13. doi: 10.1055/s-0034-1372337. Epub 2014 Apr 8. Review. PubMed PMID:
24715483; PubMed Central PMCID:
PMC4120280.
Quantification of entry phenotypes of macrophage-tropic HIV-1 across a wide range of CD4 densities.
J Virol.
2014 Feb;88(4):1858-69. doi: 10.1128/JVI.02477-13. Epub 2013 Dec 4. PubMed PMID:
24307580; PubMed Central PMCID:
PMC3911544.
The Neonatal Fc receptor (FcRn) enhances human immunodeficiency virus type 1 (HIV-1) transcytosis across epithelial cells.
PLoS Pathog.
2013;9(11):e1003776. doi: 10.1371/journal.ppat.1003776. Epub 2013 Nov 21. PubMed PMID:
24278022; PubMed Central PMCID:
PMC3836734.
Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design.
J Virol.
2013 Jul;87(13):7218-33. doi: 10.1128/JVI.03577-12. Epub 2013 Apr 24. PubMed PMID:
23616655; PubMed Central PMCID:
PMC3700278.
Central nervous system compartmentalization of HIV-1 subtype C variants early and late in infection in young children.
PLoS Pathog.
2012 Dec;8(12):e1003094. doi: 10.1371/journal.ppat.1003094. Epub 2012 Dec 27. PubMed PMID:
23300446; PubMed Central PMCID:
PMC3531524.
The HIV-1 env protein: a coat of many colors.
Curr HIV/AIDS Rep.
2012 Mar;9(1):52-63. doi: 10.1007/s11904-011-0107-3. Review. PubMed PMID:
22237899; PubMed Central PMCID:
PMC3658113.
HIV-1 replication in the central nervous system occurs in two distinct cell types.
PLoS Pathog.
2011 Oct;7(10):e1002286. doi: 10.1371/journal.ppat.1002286. Epub 2011 Oct 6. PubMed PMID:
22007152; PubMed Central PMCID:
PMC3188520.
A high frequency of beneficial mutations across multiple fitness components in Saccharomyces cerevisiae.
Genetics.
2010 Aug;185(4):1397-409. doi: 10.1534/genetics.110.118307. Epub 2010 Jun 1. PubMed PMID:
20516495; PubMed Central PMCID:
PMC2927765.
Coinfection rates in Φ6 bacteriophage are enhanced by virus-induced changes in host cells.
Evol Appl.
2009 Feb;2(1):24-31. doi: 10.1111/j.1752-4571.2008.00055.x. Epub 2008 Dec 23. PubMed PMID:
25567844; PubMed Central PMCID:
PMC3352419.
Spontaneous mutations in diploid Saccharomyces cerevisiae: another thousand cell generations.
Genet Res (Camb).
2008 Jun;90(3):229-41. doi: 10.1017/S0016672308009324. PubMed PMID:
18593510.
Effects of the [PSI+] prion on rates of adaptation in yeast.
J Evol Biol.
2008 May;21(3):773-80. doi: 10.1111/j.1420-9101.2008.01515.x. Epub 2008 Feb 29. PubMed PMID:
18312560.
Spontaneous mutations in diploid Saccharomyces cerevisiae: more beneficial than expected.
Genetics.
2004 Dec;168(4):1817-25. doi: 10.1534/genetics.104.033761. PubMed PMID:
15611159; PubMed Central PMCID:
PMC1448740.
What would you like to do?